Correlation Between Pfizer and Impact BioMedical,

Can any of the company-specific risk be diversified away by investing in both Pfizer and Impact BioMedical, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and Impact BioMedical, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and Impact BioMedical,, you can compare the effects of market volatilities on Pfizer and Impact BioMedical, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of Impact BioMedical,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and Impact BioMedical,.

Diversification Opportunities for Pfizer and Impact BioMedical,

0.33

Correlation Coefficient

Pfizer  Impact BioMedical,

Weak diversification

The 3 months correlation between Pfizer and Impact is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and Impact BioMedical, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Impact BioMedical, and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with Impact BioMedical,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Impact BioMedical, has no effect on the direction of Pfizer i.e., Pfizer and Impact BioMedical, go up and down completely randomly.

Pair Corralation between Pfizer and Impact BioMedical,

Considering the 90-day investment horizon Pfizer Inc is expected to generate 0.11 times more return on investment than Impact BioMedical,. However, Pfizer Inc is 9.13 times less risky than Impact BioMedical,. It trades about 0.06 of its potential returns per unit of risk. Impact BioMedical, is currently generating about -0.11 per unit of risk. If you would invest  2,535  in Pfizer Inc on December 19, 2024 and sell it today you would earn a total of  96.00  from holding Pfizer Inc or generate 3.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.33%
Values	Daily Returns

Pfizer Inc  vs.  Impact BioMedical,

Pfizer Inc

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.

Impact BioMedical,

Risk-Adjusted Performance

Very Weak

Over the last 90 days Impact BioMedical, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental drivers remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Pfizer and Impact BioMedical,

The main advantage of trading using opposite Pfizer and Impact BioMedical, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, Impact BioMedical, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Impact BioMedical, will offset losses from the drop in Impact BioMedical,'s long position.

The idea behind Pfizer Inc and Impact BioMedical, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.